Enovix Shareholder Third Reminder: Early Warrant Expiration Price Condition
Enovix (Nasdaq: ENVX) announced that its common stock has traded above $10.50 for 17 consecutive trading days since the distribution of warrants. The company's stock closed at $10.98 per share, with warrants trading $2.23 in-the-money based on their $8.75 exercise price.
If the stock continues trading above $10.50 for 20 out of 30 trading days, the warrants could expire as early as August 19, 2025. To date, approximately 7.8 million warrants have been exercised, generating about $68.5 million in gross proceeds for Enovix.
The company plans to implement a Notice of Guaranteed Delivery process for warrant exercises and encourages remaining holders to take prompt action as unexercised warrants will become worthless after expiration.
Enovix (Nasdaq: ENVX) ha annunciato che il suo titolo ordinario è stato scambiato sopra $10,50 per 17 giorni di negoziazione consecutivi dalla distribuzione dei warrant. Il titolo ha chiuso a $10,98 per azione, con i warrant che mostrano un valore intrinseco di $2,23 rispetto al prezzo di esercizio di $8,75.
Se il titolo dovesse rimanere sopra i $10,50 per 20 dei 30 giorni di negoziazione, i warrant potrebbero scadere già il 19 agosto 2025. Ad oggi sono stati esercitati circa 7,8 milioni di warrant, generando per Enovix circa $68,5 milioni di proventi lordi.
La società intende attivare una procedura di Notice of Guaranteed Delivery per l'esercizio dei warrant e invita i detentori rimanenti ad agire tempestivamente, poiché i warrant non esercitati perderanno ogni valore alla scadenza.
Enovix (Nasdaq: ENVX) anunció que su acción ordinaria se ha negociado por encima de $10.50 durante 17 jornadas consecutivas desde la emisión de los warrants. La acción cerró a $10.98 por título, y los warrants presentan un valor intrínseco de $2.23 respecto al precio de ejercicio de $8.75.
Si la acción continúa por encima de $10.50 en 20 de los 30 días de negociación, los warrants podrían expirar tan pronto como el 19 de agosto de 2025. Hasta la fecha se han ejercido aproximadamente 7,8 millones de warrants, generando alrededor de $68,5 millones en ingresos brutos para Enovix.
La compañía planea implementar un proceso de Notice of Guaranteed Delivery para el ejercicio de los warrants y anima a los titulares restantes a actuar con rapidez, ya que los warrants no ejercitados quedarán sin valor tras su vencimiento.
Enovix (Nasdaq: ENVX)는 보통주가 워런트 배포 이후 연속 17 거래일 동안 $10.50를 상회했다고 발표했습니다. 주가는 주당 $10.98로 마감했으며, 워런트는 행사가 $8.75를 기준으로 내재가치가 $2.23입니다.
만약 주가가 30거래일 중 20일 동안 $10.50를 초과하면 워런트는 2025년 8월 19일에 조기 만료될 수 있습니다. 현재까지 약 7.8백만 개의 워런트가 행사되어 Enovix에 약 $68.5 million의 총수익을 창출했습니다.
회사는 워런트 행사에 대해 Notice of Guaranteed Delivery 절차를 도입할 예정이며, 행사하지 않은 워런트는 만료 후 무가치해지므로 남아 있는 보유자들에게 신속히 조치할 것을 권장합니다.
Enovix (Nasdaq: ENVX) a annoncé que son action ordinaire s'est négociée au-dessus de $10,50 pendant 17 jours de bourse consécutifs depuis la distribution des warrants. L'action a clôturé à $10,98 par titre, et les warrants présentent une valeur intrinsèque de $2,23 sur la base d'un prix d'exercice de $8,75.
Si l'action continue de se maintenir au-dessus de $10,50 pendant 20 des 30 jours de bourse, les warrants pourraient expirer dès le 19 août 2025. À ce jour, environ 7,8 millions de warrants ont été exercés, générant pour Enovix environ $68,5 millions de produit brut.
La société prévoit de mettre en place une procédure de Notice of Guaranteed Delivery pour l'exercice des warrants et encourage les détenteurs restants à agir rapidement, car les warrants non exercés deviendront sans valeur après leur expiration.
Enovix (Nasdaq: ENVX) gab bekannt, dass seine Stammaktie seit der Ausgabe der Warrants an 17 aufeinanderfolgenden Handelstagen über $10,50 gehandelt wurde. Die Aktie schloss bei $10,98 je Aktie; die Warrants weisen auf Basis des Ausübungspreises von $8,75 einen inneren Wert von $2,23 auf.
Wenn die Aktie an 20 von 30 Handelstagen weiterhin über $10,50 notiert, könnten die Warrants bereits am 19. August 2025 verfallen. Bis heute wurden etwa 7,8 Millionen Warrants ausgeübt, was Enovix rund $68,5 Millionen Bruttoerlös eingebracht hat.
Das Unternehmen plant die Einführung eines Verfahrens namens Notice of Guaranteed Delivery für die Ausübung der Warrants und fordert verbleibende Inhaber auf, zügig zu handeln, da nicht ausgeübte Warrants nach Ablauf wertlos werden.
- Generated $68.5 million in gross proceeds from warrant exercises
- Stock trading consistently above warrant threshold price of $10.50
- Warrants currently $2.23 in-the-money, providing exercise incentive
- Unexercised warrants will become worthless after expiration date
- Limited time remaining for warrant holders to exercise their rights
- Complex exercise process may vary by broker requiring additional processing time
Insights
Enovix nears warrant early expiration threshold with 17/20 days above $10.50, already raising $68.5M for growth initiatives.
Enovix Corporation is approaching a critical milestone for its outstanding warrants (ENVXW). The company has reported that its common stock has traded above
The warrants, currently trading at
From a capital structure perspective, approximately 7.8 million warrants have already been exercised, generating
The company is implementing a Notice of Guaranteed Delivery process to facilitate last-minute exercises, signaling their expectation that the early expiration condition will indeed be met. For remaining warrant holders, the message is clear – take action quickly or face the prospect of holding worthless securities after the expiration date.
Enovix Warrants: 17 of 17 Trading Days Above
FREMONT, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded
As a reminder, under the Warrant Agreement, if our stock trades at or above
Ryan Benton, Chief Financial Officer, stated, “The strong pace of exercises to date has already delivered meaningful proceeds to support our growth initiatives, and we appreciate the many shareholders who have taken action. We encourage all remaining holders to make timely decisions regarding their Warrants. We’ve now completed 17 consecutive trading days above
As of August 12, approximately 7.8 million Warrants have been exercised, generating approximately
At 5 p.m. New York City time on the expiration date, the Warrants will no longer be exercisable and will cease trading at 4 p.m. on the expiration date. We anticipate implementing a process by which Warrant holders may cash exercise their Warrants using a Notice of Guaranteed Delivery for Exercise of Warrants. This process will be detailed further in a future notice, but it will require submission of the related notice and payment of the exercise price for the Warrants prior to the expiration of the warrants. While the Company, in its discretion, will make every effort to accommodate exercises submitted in good faith by the expiration date, we encourage all Warrant holders to ensure their Warrants are traded or exercised on a timely basis. Processing procedures and timelines may vary by broker or the institution holding your Warrants, so prompt action is recommended.
Enovix expects to provide further periodic updates, including if and when the Early Expiration Price Condition is met.
Further Information Relating to the Warrants
For more information relating to the exercise mechanics and other terms of the Warrants, please refer to the materials filed by the Company with the Securities and Exchange Commission (the “SEC”) available at https://www.sec.gov and the information posted on the Company’s website at https://www.enovix.com/enovix-warrant-dividend.
About Enovix Corporation
Enovix is a leader in advancing lithium-ion battery technology with its proprietary cell architecture designed to deliver higher energy density and improved safety. The Company’s breakthrough silicon-anode batteries are engineered to power a wide range of devices from wearable electronics and mobile communications to industrial and electric vehicle applications. Enovix’s technology enables longer battery life and faster charging, supporting the growing global demand for high-performance energy storage. Enovix holds a robust portfolio of issued and pending patents covering its core battery design and manufacturing process.
Enovix is headquartered in Silicon Valley with facilities in India, South Korea and Malaysia. For more information visit https://enovix.com and follow us on LinkedIn.
No Offer or Solicitation
This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The issuance of the Warrants has not been registered under the Securities Act of 1933, as amended (the “Securities Act”), as the distribution of a Warrant for no consideration does not constitute a sale of a security under Section 2(a)(3) of the Securities Act. A Form 8-A registration statement and prospectus supplement describing the terms of the Warrants were filed with the SEC and are available on the SEC’s website located at https://www.sec.gov. Holders of Warrants should read the prospectus supplement carefully, including the Risk Factors section included and incorporated by reference therein. This press release contains a general summary of the Warrants. Please read the Warrant Agreement filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on July 21, 2025 as it contains important information about the terms of the Warrants.
Forward‐Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, about us, the Warrants and our business that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and can be identified by words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, should, would and similar expressions that convey uncertainty about future events or outcomes. Forward-looking statements in this press release include, without limitation, our expectations regarding the Early Expiration Price Condition, our ability to accommodate good faith exercises, and the anticipated trading prices of our common stock. Actual results and outcomes could differ materially from these forward-looking statements as a result of certain risks and uncertainties, including, without limitation, those risks and uncertainties and other potential factors set forth in our filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of our most recently filed annual report on Form 10-K and quarterly reports on Form 10-Q and other documents that we have filed, or that we will file, with the SEC. For a full discussion of these risks, please refer to Enovix’s filings with the SEC, including its most recent Form 10-K and Form 10-Q, available at https://ir.enovix.com and www.sec.gov. Any forward-looking statements made by us in this press release speak only as of the date on which they are made and subsequent events may cause these expectations to change. We disclaim any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise, except as required by law.
Investor Contact:
Robert Lahey
ir@enovix.com
Chief Financial Officer:
Ryan Benton
ryan.benton@enovix.com
FAQ
When will Enovix (ENVX) warrants expire?
How many Enovix (ENVX) warrants have been exercised so far?
What is the exercise price for Enovix (ENVX) warrants?
What happens to unexercised Enovix (ENVX) warrants after expiration?
How can Enovix (ENVX) warrant holders exercise their warrants?
